Business
Bausch Health Appoints New Chief Medical Officer and Head of R&D
LAVAL, QC / ACCESSWIRE / December 2, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is ...
About this update from Bausch Health Companies Inc.
[{"type":"text","content":"Bausch Health Appoints New Chief Medical Officer and Head of R&DLAVAL, QC / ACCESSWIRE / December 2, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is pleased to announce the appointment of Jonathan Sadeh M.D., M.Sc as Executive Vice President, Chief Medical Officer and Head of R&D. This strategic addition to our leadership team underscores our commitment to innovation, excellence, and enriching lives.Jonathan brings a wealth of experience and a proven track record of success both as a physician-scientist and a leader in the pharmaceutical industry. With over 20 years of expertise in clinical research and drug development, he has consistently demonstrated the ability to drive growth and foster innovation. Most recently, at Bristol-Meyers Squibb, he was responsible for multiple drug approvals in dermatology and gastroenterology and held several key roles including Senior Vice President and Global Programs Head for Immunology, Cardiovascular and Neuroscience, Immunology Therapeutic Area Head, as well as the China R&D Head. Jonathan received a master's degree in clinical research from Harvard Medical School and earned his medical degree from the Mount Sinai School of Medicine. He has held key positions at Sanofi, Astra-Zeneca and Schering-Plough.\"We are delighted to welcome Jonathan as our new Head of Research and Development,\" said CEO, Thomas J. Appio. \"His extensive experience and innovative vision will be invaluable as we continue to enhance our pipeline and strive for groundbreaking advancements.\"In his new role, Jonathan will be responsible for overseeing the entire R&D process, working closely with our scientists and engineers. He will set the strategic direction and ensure alignment with our overall goal of enriching lives through our relentless drive to deliver better health outcomes. We are confident that Jonathan will make a significant contribution to our company's success and commitment to being an innovative healthcare company.About Bausch HealthBausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, medical aesthetic devices, international pharmaceut...